Related references
Note: Only part of the references are listed.AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
Mihaly Varadi et al.
NUCLEIC ACIDS RESEARCH (2022)
Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
Junhao Liu et al.
MOLECULAR ONCOLOGY (2021)
CB-Dock: a web server for cavity detection-guided protein-ligand blind docking
Yang Liu et al.
ACTA PHARMACOLOGICA SINICA (2020)
EDock: blind protein-ligand docking by replica-exchange monte carlo simulation
Wenyi Zhang et al.
JOURNAL OF CHEMINFORMATICS (2020)
Vps11 and Vps18 of Vps-C membrane traffic complexes are E3 ubiquitin ligases and fine-tune signalling
Gregory Segala et al.
NATURE COMMUNICATIONS (2019)
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Suryavathi Viswanadhapalli et al.
BREAST CANCER RESEARCH (2019)
Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
G. R. Sareddy et al.
ONCOGENE (2017)
Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists
Weiyi Toy et al.
CANCER DISCOVERY (2017)
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer
Nicholas C. Turner et al.
LANCET (2017)
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
Ganesh V. Raj et al.
ELIFE (2017)
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
Amir Bahreini et al.
BREAST CANCER RESEARCH (2017)
PELP1: Structure, biological function and clinical significance
Gangadhara Reddy Sareddy et al.
GENE (2016)
Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer
Bartosz Kazimierz Slowikowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Steroid receptor coactivators as therapeutic targets in the female reproductive system
Maria M. Szwarc et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer
Rinath Jeselsohn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
PELP1 Overexpression in the Mouse Mammary Gland Results in the Development of Hyperplasia and Carcinoma
Valerie Cortez et al.
CANCER RESEARCH (2014)
Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology
Subhamoy Dasgupta et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
PELP1: A review of PELP1 interactions, signaling, and biology
Brian J. Girard et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
PELP1 oncogenic functions involve alternative splicing via PRIVIT6
Monica Mann et al.
MOLECULAR ONCOLOGY (2014)
PELP1 Suppression Inhibits Colorectal Cancer through c-Src Downregulation
Zhifeng Ning et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
PELP1 oncogenic functions involve CARM1 regulation
Monica Mann et al.
CARCINOGENESIS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
The search for ESR1 mutations in breast cancer
Steffi Oesterreich et al.
NATURE GENETICS (2013)
KDM1 is a novel therapeutic target for the treatment of gliomas
Gangadhara R. Sareddy et al.
ONCOTARGET (2013)
High-Throughput parallel blind Virtual Screening using BINDSURF
Irene Sanchez-Linares et al.
BMC BIOINFORMATICS (2012)
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
Andreas W. Goetz et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Therapeutic Significance of Estrogen Receptor β Agonists in Gliomas
Gangadhara R. Sareddy et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer
Lin Yang et al.
MOLECULAR ENDOCRINOLOGY (2012)
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
Valerie Cortez et al.
BREAST CANCER RESEARCH (2012)
Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis
Dimple Chakravarty et al.
CLINICAL CANCER RESEARCH (2011)
Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
Binoj C. Nair et al.
BREAST CANCER RESEARCH (2011)
The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype
Hany Onsy Habashy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cyclin-Dependent Kinase-Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1
Binoj C. Nair et al.
CANCER RESEARCH (2010)
Involvement of the Tubulin Tyrosine Ligase-Like Family Member 4 Polyglutamylase in PELP1 Polyglutamylation and Chromatin Remodeling in Pancreatic Cancer Cells
Kotoe Kashiwaya et al.
CANCER RESEARCH (2010)
PELP1: A Novel Therapeutic Target for Hormonal Cancers
Dimple Chakravarty et al.
IUBMB LIFE (2010)
Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
Paul C. D. Hawkins et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor
Rajib Rajhans et al.
CANCER RESEARCH (2007)
Identifying novel proteins recognizing histone modifications using peptide pull-down assay
Joanna Wysocka
METHODS (2006)
Steering estrogen signals from the plasma membrane to the nucleus: Two sides of the coin
B Manavathi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Novel estrogen receptor coactivator PELP1/MNAR gene and ERβ expression in salivary duct adenocarcinoma:: potential therapeutic targets
RK Vadlamudi et al.
HUMAN PATHOLOGY (2005)
Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors
RK Vadlamudi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Share Paper
